Taficita™ (30 tabs) is a licensed generic of Descovy® (Tenofovir Alafenamide / Emtricitabine) which is a prescription medicine approved by the U.S. FDA for use as HIV-1 PrEP (pre-exposure prophylaxis) in men weighing at least 77 pounds (35 kg). It’s also approved by the U.S. FDA for use with other HIV-1 medications to treat HIV-1 infection in people who weigh at least 77 pounds (35 kg).
- Taficita™ (Tenofovir Alafenamide) is a novel Tenofovir prodrug with a 90% reduction in plasma Tenofovir concentrations.
- Tenofovir Alafenamide containing regimens have improved bone safety compared with Tenofovir Disoproxil Fumarate containing regimens.
Active Ingredients : Tenofovir Alafenamide 25 mg / Emtricitabine 200 mg
Produced by Mylan Pharmaceuticals Ltd of the United States (US FDA cGMP certified manufacturer)